Found 42 matching trials
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency PHASE3 The purpose of this trial is to compare the 3-year disease-free survival of...
Show More Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Combination Therapy of Anthracyclines for Children With Nephroblastoma PHASE4 This study aims to estimate the efficacy and side effects of study drugs in...
Show More Location
Shenjing Hospital
Learn More & Join Trial
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma PHASE3 Primary Objective:
To compare the efficacy of TACE vs. CyberKnife SBRT in ...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer PHASE3 In this trial investigators propose to assess the dose dense, G-CSF support...
Show More Location
University Hospital of Crete
Learn More & Join Trial
Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes PHASE3 The purpose of this study is to determine whether a treatment with 4 cycles...
Show More Location
Oskar-Ziethen-Krankenhaus
Learn More & Join Trial
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer PHASE3 Anthracycline-containing regimens are recommended as adjuvant treatment for...
Show More Location
University Hospital of Crete
Learn More & Join Trial
A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma PHASE2 To evaluate the efficacy and safety of bortezomib combined with CHEP regime...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. PHASE1 The study has a phase Ib and a phase II part.
* The phase Ib aims to evalu...
Show More Location
Grand Hôpital de Charleroi
Learn More & Join Trial
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer PHASE3 This trial will compare 6 versus 12 months of trastuzumab in combination wi...
Show More Location
University Hospital of Crete
Learn More & Join Trial
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC PHASE3 The purpose of this trial is to compare the 3 years DFS of dose-dense epiru...
Show More Location
Cancer institute and hospital Chinese academy of medical sciences
Learn More & Join Trial